Heater probe thermocoagulation for high-risk patients who show rebleeding from peptic ulcers

Yu Hsi Hsieh, Hwai Jeng Lin

研究成果: 雜誌貢獻文章

摘要

Aim To investigate whether heater probe therapy is effective for patients showing rebleeding from peptic ulcers. Methods We retrospectively reviewed the case profiles in our previous studies on endoscopic therapy for high-risk patients with peptic ulcer bleeding in the past two decades. We analysed the outcomes of 191 patients who showed rebleeding after initial endoscopic haemostasis and received endoscopic therapy with heater probe thermocoagulation. Results A total of 191 patients showing rebleeding received heater probe thermocoagulation. After re-therapy, 158 patients (82.7%) achieved ultimate haemostasis. Twenty-five of the 33 patients who failed to achieve haemostasis received surgical intervention. Ten patients (5.2%) died within 1 month after retherapy. Conclusion Heater probe thermocoagulation can be used as the first choice for management of patients showing rebleeding after initial endoscopic therapy.

原文英語
期刊The New Zealand medical journal
124
發行號1341
出版狀態已發佈 - 2011

指紋

Electrocoagulation
Peptic Ulcer
Hemostasis
Endoscopic Hemostasis
Therapeutics
Hemorrhage

ASJC Scopus subject areas

  • Medicine(all)

引用此文

@article{8946db5a671c47309ac637476c5832e3,
title = "Heater probe thermocoagulation for high-risk patients who show rebleeding from peptic ulcers",
abstract = "Aim To investigate whether heater probe therapy is effective for patients showing rebleeding from peptic ulcers. Methods We retrospectively reviewed the case profiles in our previous studies on endoscopic therapy for high-risk patients with peptic ulcer bleeding in the past two decades. We analysed the outcomes of 191 patients who showed rebleeding after initial endoscopic haemostasis and received endoscopic therapy with heater probe thermocoagulation. Results A total of 191 patients showing rebleeding received heater probe thermocoagulation. After re-therapy, 158 patients (82.7{\%}) achieved ultimate haemostasis. Twenty-five of the 33 patients who failed to achieve haemostasis received surgical intervention. Ten patients (5.2{\%}) died within 1 month after retherapy. Conclusion Heater probe thermocoagulation can be used as the first choice for management of patients showing rebleeding after initial endoscopic therapy.",
author = "Hsieh, {Yu Hsi} and Lin, {Hwai Jeng}",
year = "2011",
language = "English",
volume = "124",
journal = "New Zealand Medical Journal",
issn = "0028-8446",
publisher = "New Zealand Medical Association",
number = "1341",

}

TY - JOUR

T1 - Heater probe thermocoagulation for high-risk patients who show rebleeding from peptic ulcers

AU - Hsieh, Yu Hsi

AU - Lin, Hwai Jeng

PY - 2011

Y1 - 2011

N2 - Aim To investigate whether heater probe therapy is effective for patients showing rebleeding from peptic ulcers. Methods We retrospectively reviewed the case profiles in our previous studies on endoscopic therapy for high-risk patients with peptic ulcer bleeding in the past two decades. We analysed the outcomes of 191 patients who showed rebleeding after initial endoscopic haemostasis and received endoscopic therapy with heater probe thermocoagulation. Results A total of 191 patients showing rebleeding received heater probe thermocoagulation. After re-therapy, 158 patients (82.7%) achieved ultimate haemostasis. Twenty-five of the 33 patients who failed to achieve haemostasis received surgical intervention. Ten patients (5.2%) died within 1 month after retherapy. Conclusion Heater probe thermocoagulation can be used as the first choice for management of patients showing rebleeding after initial endoscopic therapy.

AB - Aim To investigate whether heater probe therapy is effective for patients showing rebleeding from peptic ulcers. Methods We retrospectively reviewed the case profiles in our previous studies on endoscopic therapy for high-risk patients with peptic ulcer bleeding in the past two decades. We analysed the outcomes of 191 patients who showed rebleeding after initial endoscopic haemostasis and received endoscopic therapy with heater probe thermocoagulation. Results A total of 191 patients showing rebleeding received heater probe thermocoagulation. After re-therapy, 158 patients (82.7%) achieved ultimate haemostasis. Twenty-five of the 33 patients who failed to achieve haemostasis received surgical intervention. Ten patients (5.2%) died within 1 month after retherapy. Conclusion Heater probe thermocoagulation can be used as the first choice for management of patients showing rebleeding after initial endoscopic therapy.

UR - http://www.scopus.com/inward/record.url?scp=80052229112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052229112&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:80052229112

VL - 124

JO - New Zealand Medical Journal

JF - New Zealand Medical Journal

SN - 0028-8446

IS - 1341

ER -